Diabetes type 2. Type 2 diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Middle Aged WWomen are 30 to 59 Years Old. Have a one Year or more History of type 2 Diabetes. Willing to Participate in the Study. Use Oral Medications to Control your Blood Sugar. Do not take Insulin. Pregnant and lactating. Do not have any Special iIlnesses. Have no Thyroid Problems. There is no Definite Diet. Do not have Uncontrolled Diabetes. Have Mental Disabilities. Sleep, Tranquilizer, Antihistamines and Immune System Inhibitors.
Exclusion criteria
Exclusion criteria: One does not want to Continue to Study. The Person will Absent more than one Meeting. The Person leaves the Pre-test or Post-test. Tests are Misleading.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood glucose above 126mg / dl and high blood glucose levels of 180mg / dl. Timepoint: The beginning of the study (before intervention) and three months after the intervention began. Method of measurement: blood test.;Hemogolobin A1C above 6.5%. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Koromatografi.;Fasting Ansulin. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Fasting serum insulin concentration using a commercial kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Weight. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Weight using seca scales with an accuracy of one hundred grams.;Waist. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Scales.;Body mass index. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Ratio of weight(in terms of kilogram) to the power of height(in terms of meters).;Blood pressure. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Using a standard mercury barometer.;High density of lipoprotein cholestrol. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Blood test.;Low density of lipoprotein cholestrol. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Blood test.;Triglyceride. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Blood test.;Cholesterol. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Blood test.;Alanine trans aminase. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Blood test.;Aspartate transaminase. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Blood test.;Homeostasis model assessment beta cell. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Based on fasting glucose and insulin concentrations.;Homeostasis model assessment insulin | — |
Countries
Iran (Islamic Republic of)
Contacts
Shiraz University of Medical Sciences